 treatment advanc neuroblastoma emphasi intens induct chemotherapi report studi group japan patient advanc neuroblastoma studi januari may elig patient infant month age stage iva diseas bone cortex distant lymph node and/or organ metastas patient month stage iii IV diseas iva ivb tumor mid-lin metastas marrow liver skin patient cyclic cours intens chemotherapi regimen cyclophosphamid vincristin tetrahydropyranyl adriamycin pyrarubicin cisplatin origin tumor region lymph node metastas time first cycl chemotherapi patient group patient cours treatment regimen cyclophosphamid acnu intensifi regimen cours administr regimen cyclophosphamid dtic intensifi patient cours bone marrow transplant bmt high-dos precondit chemotherapi surviv rate stage iii stage IV year stage iii stage IV year major toxic bone marrow suppress leukocyt count mild cystiti impair surviv rate patient bmt complet remiss intens induct chemotherapi signific valu rate complet respons indic improv result treatment bmt